Published in Cancer Res on March 01, 1976
Integration of murine leukemia virus DNA depends on mitosis. EMBO J (1993) 7.62
Functions of microtubules in the Saccharomyces cerevisiae cell cycle. J Cell Biol (1988) 7.19
Tubulin dynamics in cultured mammalian cells. J Cell Biol (1984) 6.46
Retrieval of transmembrane proteins to the endoplasmic reticulum. J Cell Biol (1993) 3.67
Associations of elements of the Golgi apparatus with microtubules. J Cell Biol (1984) 3.42
Taxol induces the assembly of free microtubules in living cells and blocks the organizing capacity of the centrosomes and kinetochores. Proc Natl Acad Sci U S A (1981) 3.40
Establishment of a functional human immunodeficiency virus type 1 (HIV-1) reverse transcription complex involves the cytoskeleton. J Exp Med (1998) 3.22
Taxol suppresses dynamics of individual microtubules in living human tumor cells. Mol Biol Cell (1999) 3.14
Nanomolar concentrations of nocodazole alter microtubule dynamic instability in vivo and in vitro. Mol Biol Cell (1997) 3.05
Effect of microtubule assembly status on the intracellular processing and surface expression of an integral protein of the plasma membrane. J Cell Biol (1984) 2.68
Perturbation of the morphology of the trans-Golgi network following Brefeldin A treatment: redistribution of a TGN-specific integral membrane protein, TGN38. J Cell Biol (1992) 2.66
An N-terminal double-arginine motif maintains type II membrane proteins in the endoplasmic reticulum. EMBO J (1994) 2.65
Differential binding of methyl benzimidazol-2-yl carbamate to fungal tubulin as a mechanism of resistance to this antimitotic agent in mutant strains of Aspergillus nidulans. J Cell Biol (1977) 2.41
Microtubule-acting drugs lead to the nonpolarized delivery of the influenza hemagglutinin to the cell surface of polarized Madin-Darby canine kidney cells. J Cell Biol (1987) 2.29
Checkpoint genes required to delay cell division in response to nocodazole respond to impaired kinetochore function in the yeast Saccharomyces cerevisiae. Mol Cell Biol (1995) 2.14
Non-sarcomeric mode of myosin II organization in the fibroblast lamellum. J Cell Biol (1993) 2.10
Retracted IgG transcytosis and recycling by FcRn expressed in MDCK cells reveals ligand-induced redistribution. EMBO J (2002) 1.94
TGN38/41 recycles between the cell surface and the TGN: brefeldin A affects its rate of return to the TGN. Mol Biol Cell (1993) 1.87
Requirements for different components of the host cell cytoskeleton distinguish ecotropic murine leukemia virus entry via endocytosis from entry via surface fusion. J Virol (1997) 1.75
A master relation defines the nonlinear viscoelasticity of single fibroblasts. Biophys J (2006) 1.74
Using single-particle tracking to study nuclear trafficking of viral genes. Biophys J (2004) 1.72
Cytoskeletal control of gene expression: depolymerization of microtubules activates NF-kappa B. J Cell Biol (1995) 1.65
The Golgi apparatus remains associated with microtubule organizing centers during myogenesis. J Cell Biol (1985) 1.63
Phagocytosis of Histoplasma capsulatum yeasts and microconidia by human cultured macrophages and alveolar macrophages. Cellular cytoskeleton requirement for attachment and ingestion. J Clin Invest (1990) 1.59
Newly synthesized G protein of vesicular stomatitis virus is not transported to the cell surface during mitosis. J Cell Biol (1983) 1.53
Multiple regulatory effects of varicella-zoster virus (VZV) gL on trafficking patterns and fusogenic properties of VZV gH. J Virol (1996) 1.49
Effect of nocodazole on vesicular traffic to the apical and basolateral surfaces of polarized MDCK cells. J Cell Biol (1990) 1.48
Transcription-coupled and DNA damage-dependent ubiquitination of RNA polymerase II in vitro. Proc Natl Acad Sci U S A (2002) 1.45
Soluble levels of cytosolic tubulin regulate ciliary length control. Mol Biol Cell (2011) 1.41
Ubiquitin hydrolase Dub3 promotes oncogenic transformation by stabilizing Cdc25A. Nat Cell Biol (2010) 1.41
Mitosis-specific phosphorylation of nucleolin by p34cdc2 protein kinase. Mol Cell Biol (1990) 1.40
Impaired microtubule function correctable by cyclic GMP and cholinergic agonists in the Chediak-Higashi syndrome. Am J Pathol (1976) 1.37
Transcytosis of Listeria monocytogenes across the intestinal barrier upon specific targeting of goblet cell accessible E-cadherin. J Exp Med (2011) 1.36
Stimulated release of histamine by a rat mast cell line is inhibited during mitosis. J Cell Biol (1984) 1.36
The protein encoded by the US3 orthologue of Marek's disease virus is required for efficient de-envelopment of perinuclear virions and involved in actin stress fiber breakdown. J Virol (2005) 1.35
Biochemical characterization and subcellular localization of human copper transporter 1 (hCTR1). Biochem J (2002) 1.29
Distinct pathways for basolateral targeting of membrane and secretory proteins in polarized epithelial cells. Proc Natl Acad Sci U S A (1991) 1.27
Retention of autoregulatory control of tubulin synthesis in cytoplasts: demonstration of a cytoplasmic mechanism that regulates the level of tubulin expression. J Cell Biol (1985) 1.23
Subversion of actin dynamics by EspM effectors of attaching and effacing bacterial pathogens. Cell Microbiol (2008) 1.14
Effects of tubulin acetylation and tubulin acetyltransferase binding on microtubule structure. Mol Biol Cell (2013) 1.14
Genetic analysis of resistance to benzimidazoles in Physarum: differential expression of beta-tubulin genes. Genetics (1984) 1.06
Density-dependent stimulation and inhibition of cell growth by agents that disrupt microtubules. Proc Natl Acad Sci U S A (1980) 1.01
Characterization of human phosphoserine aminotransferase involved in the phosphorylated pathway of L-serine biosynthesis. Biochem J (2003) 1.01
Intracellular free calcium oscillates during cell division of Xenopus embryos. J Cell Biol (1991) 0.99
Intermediate filaments in monkey kidney TC7 cells: focal centers and interrelationship with other cytoskeletal systems. Proc Natl Acad Sci U S A (1984) 0.99
Microtubule perturbation inhibits intracellular transport of an apical membrane glycoprotein in a substrate-dependent manner in polarized Madin-Darby canine kidney epithelial cells. Cell Regul (1990) 0.97
SUMO1 modification stabilizes CDK6 protein and drives the cell cycle and glioblastoma progression. Nat Commun (2014) 0.96
Transcellular passage of Neisseria meningitidis across a polarized respiratory epithelium. Infect Immun (2010) 0.95
Hypertonic stress promotes autophagy and microtubule-dependent autophagosomal clusters. Autophagy (2013) 0.94
Modulation of Golgi-associated microtubule nucleation throughout the cell cycle. Cytoskeleton (Hoboken) (2012) 0.93
Reconstruction of appropriate tubulin and actin gene regulation after transient transfection of cloned beta-tubulin and beta-actin genes. Mol Cell Biol (1985) 0.92
Specific polar subpopulations of astral microtubules control spindle orientation and symmetric neural stem cell division. Elife (2014) 0.90
Microtubule assembly and conanavalin A capping in lymphocytes: reappraisal using normal and abnormal human peripheral blood cells. Proc Natl Acad Sci U S A (1980) 0.89
Stimulation of capillary tube polymorph migration: an indirect glucocorticoid effect on microtubular function. Clin Exp Immunol (1978) 0.89
The cytoskeleton and the cellular traffic of the progesterone receptor. J Cell Biol (1992) 0.89
Ezrin mediates tethering of the gamma-aminobutyric acid transporter GAT1 to actin filaments via a C-terminal PDZ-interacting domain. Biophys J (2009) 0.86
Evidence for unaltered structure and in vivo assembly of microtubules in transformed cells. Proc Natl Acad Sci U S A (1978) 0.84
Rearrangement of microtubule network under biochemical and mechanical stimulations. Methods (2013) 0.83
Submembraneous microtubule cytoskeleton: regulation of microtubule assembly by heterotrimeric Gproteins. FEBS J (2008) 0.82
Effect of auristatin PHE on microtubule integrity and nuclear localization in Cryptococcus neoformans. Antimicrob Agents Chemother (2002) 0.81
Bub1-mediated adaptation of the spindle checkpoint. PLoS Genet (2011) 0.81
Effect of nocodazole on the water permeability response to vasopressin in rabbit collecting tubules perfused in vitro. J Physiol (1989) 0.80
Signal transduction through epidermal growth factor receptor is altered in HeLa monolayer cells during mitosis. Biochem J (1997) 0.80
High content image-based screening of a protease inhibitor library reveals compounds broadly active against Rift Valley fever virus and other highly pathogenic RNA viruses. PLoS Negl Trop Dis (2014) 0.80
Assessment of the Potential of CDK2 Inhibitor NU6140 to Influence the Expression of Pluripotency Markers NANOG, OCT4, and SOX2 in 2102Ep and H9 Cells. Int J Cell Biol (2014) 0.79
The role of the cytoskeleton in volume regulation and beading transitions in PC12 neurites. Biophys J (2010) 0.79
Microtubule dissassembly in vivo: intercalary destabilization and breakdown of microtubules in the heliozoan Actinocoryne contractilis. J Cell Biol (1992) 0.77
An RNA-binding protein, RNP-1, protects microtubules from nocodazole and localizes to the leading edge during cytokinesis and cell migration in Dictyostelium cells. Acta Pharmacol Sin (2016) 0.75
Hippocampal Hyperexcitability is Modulated by Microtubule-Active Agent: Evidence from In Vivo and In Vitro Epilepsy Models in the Rat. Front Cell Neurosci (2016) 0.75
Anticancer activity of a novel small molecule tubulin inhibitor STK899704. PLoS One (2017) 0.75
Image-based compound profiling reveals a dual inhibitor of tyrosine kinase and microtubule polymerization. Sci Rep (2016) 0.75
Downregulation of FOXP1 Inhibits Cell Proliferation in Hepatocellular Carcinoma by Inducing G1/S Phase Cell Cycle Arrest. Int J Mol Sci (2016) 0.75
Systematic Identification of Determinants for Single Strand Annealing Mediated Deletion Formation in Saccharomyces cerevisiae. G3 (Bethesda) (2017) 0.75
Tetramisole (R 8299), a new, potent broad spectrum anthelmintic. Nature (1966) 30.39
Inhibition of plasminogen activators or matrix metalloproteinases prevents cardiac rupture but impairs therapeutic angiogenesis and causes cardiac failure. Nat Med (1999) 4.85
Locations of anti-AIDS drug binding sites and resistance mutations in the three-dimensional structure of HIV-1 reverse transcriptase. Implications for mechanisms of drug inhibition and resistance. J Mol Biol (1994) 3.85
Mechanisms of chronic regional postischemic dysfunction in humans. New insights from the study of noninfarcted collateral-dependent myocardium. Circulation (1993) 3.78
Receptor binding profile of R 41 468, a novel antagonist at 5-HT2 receptors. Life Sci (1981) 3.71
Accumulation of ultrasmall superparamagnetic particles of iron oxide in human atherosclerotic plaques can be detected by in vivo magnetic resonance imaging. Circulation (2003) 3.58
Vascular effects of ketanserin (R 41 468), a novel antagonist of 5-HT2 serotonergic receptors. J Pharmacol Exp Ther (1981) 3.47
Contribution of mutations in the cytochrome P450 14alpha-demethylase (Erg11p, Cyp51p) to azole resistance in Candida albicans. Microbiology (1999) 3.19
Structural changes of atrial myocardium due to sustained atrial fibrillation in the goat. Circulation (1997) 2.52
Dissociation of cardiomyocyte apoptosis and dedifferentiation in infarct border zones. Eur Heart J (2002) 2.41
An antiviral target on reverse transcriptase of human immunodeficiency virus type 1 revealed by tetrahydroimidazo-[4,5,1-jk] [1,4]benzodiazepin-2 (1H)-one and -thione derivatives. Proc Natl Acad Sci U S A (1991) 2.37
The preparation and antimycotic properties of derivatives of 1-phenethylimidazole. J Med Chem (1969) 2.28
Ketoconazole -- a new broad spectrum orally active antimycotic. Experientia (1979) 2.24
Mutation in cytochrome P-450-dependent 14 alpha-demethylase results in decreased affinity for azole antifungals. Biochem Soc Trans (1990) 2.22
Two groups of rhinoviruses revealed by a panel of antiviral compounds present sequence divergence and differential pathogenicity. J Virol (1990) 2.19
Transient expression of phosphatidylserine at cell-cell contact areas is required for myotube formation. J Cell Sci (2001) 2.03
Inhibition and induction of microsomal enzymes in rat. A comparative study of four antimycotics: miconazole, econazole, clotrimazole and ketoconazole. Arch Int Pharmacodyn Ther (1981) 2.00
Adult rabbit cardiomyocytes undergo hibernation-like dedifferentiation when co-cultured with cardiac fibroblasts. Cardiovasc Res (2001) 1.85
Itraconazole, a new triazole that is orally active in aspergillosis. Antimicrob Agents Chemother (1984) 1.83
Delay of castor oil diarrhoea in rats: a new way to evaluate inhibitors of prostaglandin biosynthesis. J Pharm Pharmacol (1978) 1.76
Chronic myocardial hibernation in humans. From bedside to bench. Circulation (1997) 1.73
Photochemical stroke model: flunarizine prevents sensorimotor deficits after neocortical infarcts in rats. Stroke (1989) 1.70
The ultrastructure of Candida albicans after in vitro treatment with miconazole. Sabouraudia (1974) 1.69
Mechanism of action of antifungal drugs, with special reference to the imidazole derivatives. Rev Infect Dis (1981) 1.67
Crystal structures of 8-Cl and 9-Cl TIBO complexed with wild-type HIV-1 RT and 8-Cl TIBO complexed with the Tyr181Cys HIV-1 RT drug-resistant mutant. J Mol Biol (1996) 1.65
Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 1: in vivo oral pharmacology and acute toxicity. Comparison with morphine, codeine, diphenoxylate and difenoxine. Arzneimittelforschung (1974) 1.65
Activity of orally, topically, and parenterally administered itraconazole in the treatment of superficial and deep mycoses: animal models. Rev Infect Dis (1987) 1.64
Temporal and spatial variations in structural protein expression during the progression from stunned to hibernating myocardium. Circulation (2004) 1.56
The mechanism of action of the new antimycotic ketoconazole. Am J Med (1983) 1.55
Structure of HIV-1 RT/TIBO R 86183 complex reveals similarity in the binding of diverse nonnucleoside inhibitors. Nat Struct Biol (1995) 1.53
Licensed midwife-attended, out-of-hospital births in Washington state: are they safe? Birth (1994) 1.52
The antiinflammatory effects of ketoconazole. A comparative study with hydrocortisone acetate in a model using living and killed Staphylococcus aureus on the skin of guinea-pigs. J Am Acad Dermatol (1991) 1.52
ALCAPA syndrome: an example of chronic myocardial hypoperfusion? J Am Coll Cardiol (1994) 1.52
Histological alterations in chronically hypoperfused myocardium. Correlation with PET findings. Circulation (1994) 1.52
A TIBO derivative, R82913, is a potent inhibitor of HIV-1 reverse transcriptase with heteropolymer templates. Antiviral Res (1991) 1.51
Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 3: in vitro studies on the peristaltic reflex and other experiments on isolated tissues. Arzneimittelforschung (1974) 1.51
In vitro activity of R 61837, a new antirhinovirus compound. Arch Virol (1988) 1.49
Evidence against interconversion of microtubules and filaments. Nature (1975) 1.47
Promotion of pseudomycelium formation of Candida albicans in culture: a morphological study of the effects of miconazole and ketoconazole. Postgrad Med J (1979) 1.47
The activity of ketoconazole in mixed cultures of fungi and human fibroblasts. Mykosen (1980) 1.47
Evolution of anti-HIV drug candidates. Part 3: Diarylpyrimidine (DAPY) analogues. Bioorg Med Chem Lett (2001) 1.44
The preservation of subcellular organelles of Candida albicans with conventional fixatives. J Cell Biol (1974) 1.44
In vitro activity of pirodavir (R 77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activity. Antimicrob Agents Chemother (1992) 1.42
Time course of functional recovery after coronary artery bypass graft surgery in patients with chronic left ventricular ischemic dysfunction. Am J Cardiol (2000) 1.42
Safety and efficacy of intranasal pirodavir (R77975) in experimental rhinovirus infection. Antimicrob Agents Chemother (1992) 1.41
Biochemical approaches to selective antifungal activity. Focus on azole antifungals. Mycoses (1989) 1.38
The activity of ketoconazole in mixed cultures of leukocytes and Candida albicans. Sabouraudia (1980) 1.37
A direct lead method for the electron microscopic visualization of alkaline phosphatase activity. J Histochem Cytochem (1966) 1.36
The absolute configurations of the optical isomers of the broad spectrum anthelmintic tetramisole. Tetrahedron Lett (1967) 1.36
Is it possible to predict the clinical effects of neuroleptic drugs (major tranquillizers) from animal data? IV. An improved experimental design for measuring the inhibitory effects of neuroleptic drugs on amphetamine-or apomorphine-induced "Cheroing" and "agitation" in rats. Arzneimittelforschung (1967) 1.33
Suppression of colds in human volunteers challenged with rhinovirus by a new synthetic drug (R61837). Antimicrob Agents Chemother (1989) 1.33
Hepatic reactions during ketoconazole treatment. Am J Med (1983) 1.32
Identifying women at-risk for postpartum depression in the immediate postpartum period. Acta Psychiatr Scand (2004) 1.30
Loperamide (R 18 553), a novel type of antidiarrheal agent. Part 2: in vivo parenteral pharmacology and acute toxicity in mice. Comparison with morphine, codeine and diphenoxylate. Arzneimittelforschung (1974) 1.30
Biochemical profile of risperidone, a new antipsychotic. J Pharmacol Exp Ther (1988) 1.29
The Lys103Asn mutation of HIV-1 RT: a novel mechanism of drug resistance. J Mol Biol (2001) 1.29
Interaction between 5-hydroxytryptamine and other vasoconstrictor substances in the isolated femoral artery of the rabbit; effect of ketanserin (R 41 468). Eur J Pharmacol (1982) 1.29
Domperidone, a novel and safe gastrokinetic anti-nauseant for the treatment of dyspepsia and vomiting. Arzneimittelforschung (1978) 1.28
Motor-stimulating properties of cisapride on isolated gastrointestinal preparations of the guinea pig. J Pharmacol Exp Ther (1985) 1.26
Etomidate, R-(+)-ethyl-1-( -methyl-benzyl)imidazole-5-carboxylate (R 16659), a potent, short-acting and relatively atoxic intravenous hypnotic agent in rats. Arzneimittelforschung (1971) 1.24
The biochemical mechanism of action of the antinematodal drug tetramisole. Biochem Pharmacol (1969) 1.24
Absorption of horseradish peroxidase by the mucosal cells of the duodenum of mouse. I. The fasting animal. J Histochem Cytochem (1968) 1.24
Cytochemical and biochemical studies of yeasts after in vitro exposure to miconazole. Antimicrob Agents Chemother (1977) 1.23
Pathophysiological mechanisms of chronic reversible left ventricular dysfunction due to coronary artery disease (hibernating myocardium). Circulation (1997) 1.22
The separation and characterization of liver plasma membrane fragments circulating in the blood of patients with cholestasis. Clin Chim Acta (1975) 1.22
Prediction of binding affinities for TIBO inhibitors of HIV-1 reverse transcriptase using Monte Carlo simulations in a linear response method. J Med Chem (1998) 1.20
New antihistaminic N-heterocyclic 4-piperidinamines. 3. Synthesis and antihistaminic activity of N-(4-piperidinyl)-3H-imidazo[4,5-b]pyridin-2-amines. J Med Chem (1985) 1.20
The inhibition of alkaline phosphatase by L-p-bromotetramisole. Histochemistry (1975) 1.19
Ketoconazole in experimental candidosis. Rev Infect Dis (1981) 1.19
Pharmacological and hemodynamic profile of nebivolol, a chemically novel, potent, and selective beta 1-adrenergic antagonist. J Cardiovasc Pharmacol (1988) 1.18
Intranasal pirodavir (R77,975) treatment of rhinovirus colds. Antimicrob Agents Chemother (1995) 1.18
Mitochondrial alterations caused by defective peroxisomal biogenesis in a mouse model for Zellweger syndrome (PEX5 knockout mouse). Am J Pathol (2001) 1.17
R115866 inhibits all-trans-retinoic acid metabolism and exerts retinoidal effects in rodents. J Pharmacol Exp Ther (2000) 1.16
Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. I. The comparative pharmacology of pimozide, haloperidol, and chlorpromazine. Arzneimittelforschung (1968) 1.16
The cytochemical application of new potent inhibitors of alkaline phosphatases. J Histochem Cytochem (1973) 1.16
Benzetimide and its optical isomers. Arzneimittelforschung (1971) 1.15
Mechanisms of action of loperamide. Scand J Gastroenterol Suppl (1984) 1.15
Degenerative changes in fungi after itraconazole treatment. Rev Infect Dis (1987) 1.14
Influence of the anthelmintic mebendazole on microtubules and intracellular organelle movement in nematode intestinal cells. Am J Vet Res (1975) 1.13
Ultrastructural localization of alkaline phosphatase activity in the absorbing cells of the duodenum of mouse. J Histochem Cytochem (1966) 1.12
Variable effects of explosive or gradual increase of intracranial pressure on myocardial structure and function. Circulation (1993) 1.12
Effect of cinnarizine on peripheral circulation in dogs. Eur J Pharmacol (1972) 1.11
Pimozide, a chemically novel, highly potent and orally long-acting neuroleptic drug. 3. Regional distribution of pimozide and of haloperidol in the dog brain. Arzneimittelforschung (1968) 1.11
Mode of action studies. Basis for the search of new antifungal drugs. Ann N Y Acad Sci (1988) 1.10
Repeated stunning precedes myocardial hibernation in progressive multiple coronary artery obstruction. J Am Coll Cardiol (1999) 1.10
Time course of atrial fibrillation-induced cellular structural remodeling in atria of the goat. J Mol Cell Cardiol (2001) 1.09
Structural remodelling during chronic atrial fibrillation: act of programmed cell survival. Cardiovasc Res (2001) 1.08
Structural and metabolic correlates of the reversibility of chronic left ventricular ischemic dysfunction in humans. Am J Physiol (1995) 1.08
In vivo pharmacology of astemizole, a new type of H1-antihistaminic compound. Arch Int Pharmacodyn Ther (1981) 1.08
The biochemical mechanism of action of the anthelmintic drug tetramisole. Life Sci (1967) 1.08
Evidence that phospholipid turnover is the signal transducing system coupled to serotonin-S2 receptor sites. J Biol Chem (1985) 1.08
Dedifferentiated cardiomyocytes from chronic hibernating myocardium are ischemia-tolerant. Mol Cell Biochem (1998) 1.07
Comparative study of the effects of flunarizine and cinnarizine on smooth muscles and cardiac tissues. Arch Int Pharmacodyn Ther (1973) 1.06
Chronic hibernating myocardium: interstitial changes. Mol Cell Biochem (1996) 1.06
Ultrastructural changes in Ascaris suum intestine after mebendazole treatment in vivo. J Parasitol (1975) 1.05
Pharmacokinetics of R 82913 in patients with AIDS or AIDS-related complex. Lancet (1991) 1.05
Scanning electron microscopy of Candida albicans after in vitro treatment with miconazole. Antimicrob Agents Chemother (1975) 1.05
Inhibition of sodium and calcium overload pathology in the myocardium: a new cytoprotective principle. Cardiovasc Res (1993) 1.05